[시장보고서]국소 흉터 치료 시장 규모, 점유율 및 동향 분석 보고서, 최종 용도별, 흉터 유형별, 제품별, 지역별 전망 및 예측(2023-2030년)

국소 흉터 치료 시장 규모, 점유율 및 동향 분석 보고서, 최종 용도별, 흉터 유형별, 제품별, 지역별 전망 및 예측(2023-2030년)

Global Topical Scar Treatment Market Size, Share & Trends Analysis Report By End-use, By Scar Type (Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks), By Product, By Regional Outlook and Forecast, 2023 - 2030

상품코드 : 1457306 해당 상품은 즉시 배송 가능합니다

리서치사 : KBV Research

발행일 : 2024년 03월

페이지 정보 : 영문 231 Pages

라이선스 & 가격 (부가세 별도)

US $ 3,600

￦ 5,341,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,320

￦ 6,409,000

PDF (Multi User License)

PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,048

￦ 8,973,000

PDF (Corporate User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

국소 흉터 치료 시장 규모는 2030년까지 289억 달러에 달할 것으로 예상되며, 예측 기간 동안 9.3%의 연평균 복합 성장률(CAGR)를 나타낼 전망입니다.

또한, 노인들은 관절 치환술에서 심장 수술에 이르기까지 다양한 건강 상태로 인해 수술을 받는 경우가 많습니다. 수술 후 흉터는 흔하게 발생하며, 국소 치료를 포함한 흉터 관리 솔루션에 대한 수요가 증가하고 있습니다. 이처럼 노인 인구 증가로 인해 시장은 크게 확대될 것으로 예상됩니다.

그러나 가처분 소득이 낮은 개인은 고가의 고급 제제를 구입하는 데 어려움을 겪을 수 있습니다. 이로 인해 인구 집단에 대한 효과적인 흉터 치료에 대한 접근성이 감소하고 시장 침투에 영향을 미칠 수 있습니다. 소비자는 종종 제품 가격에 민감하며, 고가의 제제는 잠재적인 구매자의 동기를 떨어 뜨릴 수 있습니다. 따라서 높은 비용은 시장 성장을 둔화시킬 수 있습니다.

스킨케어 산업은 다른 많은 산업과 마찬가지로 봉쇄, 이동 제한 및 제조 시설 폐쇄로 인해 공급망에 혼란을 겪었습니다. 이는 원료의 가용성과 흉터 치료 제품의 생산에 영향을 미쳤습니다. 경제의 불확실성과 소비 패턴의 변화는 소비자의 구매력에 영향을 미쳐 특수 흉터 치료를 포함한 고급 스킨케어 제품의 판매에 영향을 미칠 수 있습니다. 이와 같이 코로나19 전염병은 시장에 적당한 영향을 미쳤습니다.

북미
- 북미 시장 : 국가별
  - 미국
  - 캐나다
  - 멕시코
  - 기타 북미
유럽
- 유럽 시장 : 국가별
  - 독일
  - 영국
  - 프랑스
  - 러시아
  - 스페인
  - 이탈리아
  - 기타 유럽
아시아태평양
- 아시아태평양 시장 : 국가별
  - 중국
  - 일본
  - 인도
  - 한국
  - 싱가포르
  - 말레이시아
  - 기타 아시아태평양
라틴아메리카/중동 및 아프리카
- 라틴아메리카/중동 및 아프리카 시장 : 국가별
  - 브라질
  - 아르헨티나
  - 아랍에미리트(UAE)
  - 사우디아라비아
  - 남아프리카공화국
  - 나이지리아
  - 기타 라틴아메리카/중동 및 아프리카

제8장 기업 개요

Smith & Nephew PLC
Lumenis Be Ltd
Merz Pharma GmbH & Co KGaA
Sonoma Pharmaceuticals, Inc
Molnlycke Health Care AB
Suneva Medical, Inc
Perrigo Company PLC
Cynosure, LLC(Clayton, Dubilier & Rice, LLC)
Newmedical Technology Inc
Integra LifeSciences Holdings Corporation

제9장 국소 흉터 치료 시장을 위한 성공 필수 조건

LSH

영문 목차

영문목차

The Global Topical Scar Treatment Market size is expected to reach $28.9 billion by 2030, rising at a market growth of 9.3% CAGR during the forecast period.

Consumers in North America are often well-informed about skincare trends and are likely to seek solutions for scar reduction. Therefore, the North America region captured $5,287.0 million revenue in the market in 2022. Individuals in North America can browse and buy various skincare products, including topical scar treatments, through online retail.

Social media platforms, including Instagram, TikTok, and YouTube, provide a global stage for beauty trends and skincare routines. Influencers and beauty enthusiasts often share their skincare journeys, including scar management experiences and increasing visibility and awareness of topical scar treatments. Therefore, the market is expanding significantly due to the influence of social media and beauty trends.

Additionally, seniors often undergo surgical procedures for various health conditions, ranging from joint replacements to cardiac surgeries. Post-surgical scarring is common, creating a demand for scar management solutions, including topical treatments. Thus, because of the increasing number of senior citizens, the market is anticipated to increase significantly.

However, Individuals with lower disposable incomes may struggle to afford high-cost advanced formulations. This can reduce accessibility to effective scar treatments for population segments, impacting market penetration. Consumers are often sensitive to product prices, and high-cost formulations may discourage potential buyers. Thus, high cost can slow down the growth of the market.

The skincare industry, like many others, experienced disruptions in the supply chain due to lockdowns, restrictions on movement, and closure of manufacturing facilities. This impacted the availability of raw materials and the production of scar treatment products. Economic uncertainties and changes in consumer spending patterns affected consumers' purchasing power, potentially impacting the sales of premium skincare products, including specialized scar treatments. Thus, the COVID-19 pandemic had a moderate effect on the market.

By End-use Analysis

On the basis of end-use, the market is divided into hospitals, clinics, and homecare. In 2022, the hospitals segment dominated the market with 42.6% revenue share. Hospitals frequently use topical scar treatments to manage and minimize scarring resulting from surgical procedures. Scar prevention and reduction are essential aspects of post-operative care.

By Scar Type Analysis

Based on scar type, the market is classified into atrophic scars, hypertrophic & keloid scars, contracture scars, and stretch marks. The hypertrophic & keloid scars segment acquired 26.5% revenue share in the market in 2022. Hypertrophic & keloid scars are often associated with itching and discomfort.

By Product Analysis

By product, the market is categorized into creams, gels, silicon sheets, and others. In 2022, the creams segment held 38.1% revenue share in the market. Creams are user-friendly and easy to apply, making them convenient for individuals seeking a hassle-free scar treatment option. This ease of application encourages regular use, which is crucial for the effectiveness of scar treatments.

By Regional Analysis

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region acquired 27.1% revenue share in the market. Rising disposable income in certain countries within the Asia Pacific region allows consumers to spend more on skincare and cosmetic products, including topical scar treatments.

List of Key Companies Profiled

Smith & Nephew PLC
Lumenis Be Ltd.
Merz Pharma GmbH & Co. KGaA
Sonoma Pharmaceuticals Inc.
Molnlycke Health Care AB
Suneva Medical, Inc.
Perrigo Company PLC
Cynosure, LLC
Newmedical Technology Inc.
Integra LifeSciences Holdings Corporation

Global Topical Scar Treatment Market Report Segmentation

By End-use

Hospitals
Clinics
Homecare

By Scar Type

Atrophic Scars
Hypertrophic & Keloid Scars
Contracture Scars
Stretch Marks

By Product

Creams
Gels
Silicon Sheets
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1Global Topical Scar Treatment Market, by End-use
- 1.4.2Global Topical Scar Treatment Market, by Scar Type
- 1.4.3Global Topical Scar Treatment Market, by Product
- 1.4.4Global Topical Scar Treatment Market, by Geography
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Opportunities
- 3.2.3Market Restraints
- 3.2.4Market Challenges
3.3Porter's Five Forces Analysis

Chapter 4.Global Topical Scar Treatment Market by End-use

4.1Global Hospitals Market by Region
4.2Global Clinics Market by Region
4.3Global Homecare Market by Region

Chapter 5.Global Topical Scar Treatment Market by Scar Type

5.1Global Atrophic Scars Market by Region
5.2Global Hypertrophic & Keloid Scars Market by Region
5.3Global Contracture Scars Market by Region
5.4Global Stretch Marks Market by Region

Chapter 6.Global Topical Scar Treatment Market by Product

6.1Global Creams Market by Region
6.2Global Gels Market by Region
6.3Global Silicon Sheets Market by Region
6.4Global Others Market by Region

Chapter 7.Global Topical Scar Treatment Market by Region

7.1North America Topical Scar Treatment Market
- 7.1.1North America Topical Scar Treatment Market by End-use
  - 7.1.1.1North America Hospitals Market by Country
  - 7.1.1.2North America Clinics Market by Country
  - 7.1.1.3North America Homecare Market by Country
- 7.1.2North America Topical Scar Treatment Market by Scar Type
  - 7.1.2.1North America Atrophic Scars Market by Country
  - 7.1.2.2North America Hypertrophic & Keloid Scars Market by Country
  - 7.1.2.3North America Contracture Scars Market by Country
  - 7.1.2.4North America Stretch Marks Market by Country
- 7.1.3North America Topical Scar Treatment Market by Product
  - 7.1.3.1North America Creams Market by Country
  - 7.1.3.2North America Gels Market by Country
  - 7.1.3.3North America Silicon Sheets Market by Country
  - 7.1.3.4North America Others Market by Country
- 7.1.4North America Topical Scar Treatment Market by Country
  - 7.1.4.1US Topical Scar Treatment Market
    - 7.1.4.1.1US Topical Scar Treatment Market by End-use
    - 7.1.4.1.2US Topical Scar Treatment Market by Scar Type
    - 7.1.4.1.3US Topical Scar Treatment Market by Product
  - 7.1.4.2Canada Topical Scar Treatment Market
    - 7.1.4.2.1Canada Topical Scar Treatment Market by End-use
    - 7.1.4.2.2Canada Topical Scar Treatment Market by Scar Type
    - 7.1.4.2.3Canada Topical Scar Treatment Market by Product
  - 7.1.4.3Mexico Topical Scar Treatment Market
    - 7.1.4.3.1Mexico Topical Scar Treatment Market by End-use
    - 7.1.4.3.2Mexico Topical Scar Treatment Market by Scar Type
    - 7.1.4.3.3Mexico Topical Scar Treatment Market by Product
  - 7.1.4.4Rest of North America Topical Scar Treatment Market
    - 7.1.4.4.1Rest of North America Topical Scar Treatment Market by End-use
    - 7.1.4.4.2Rest of North America Topical Scar Treatment Market by Scar Type
    - 7.1.4.4.3Rest of North America Topical Scar Treatment Market by Product
7.2Europe Topical Scar Treatment Market
- 7.2.1Europe Topical Scar Treatment Market by End-use
  - 7.2.1.1Europe Hospitals Market by Country
  - 7.2.1.2Europe Clinics Market by Country
  - 7.2.1.3Europe Homecare Market by Country
- 7.2.2Europe Topical Scar Treatment Market by Scar Type
  - 7.2.2.1Europe Atrophic Scars Market by Country
  - 7.2.2.2Europe Hypertrophic & Keloid Scars Market by Country
  - 7.2.2.3Europe Contracture Scars Market by Country
  - 7.2.2.4Europe Stretch Marks Market by Country
- 7.2.3Europe Topical Scar Treatment Market by Product
  - 7.2.3.1Europe Creams Market by Country
  - 7.2.3.2Europe Gels Market by Country
  - 7.2.3.3Europe Silicon Sheets Market by Country
  - 7.2.3.4Europe Others Market by Country
- 7.2.4Europe Topical Scar Treatment Market by Country
  - 7.2.4.1Germany Topical Scar Treatment Market
    - 7.2.4.1.1Germany Topical Scar Treatment Market by End-use
    - 7.2.4.1.2Germany Topical Scar Treatment Market by Scar Type
    - 7.2.4.1.3Germany Topical Scar Treatment Market by Product
  - 7.2.4.2UK Topical Scar Treatment Market
    - 7.2.4.2.1UK Topical Scar Treatment Market by End-use
    - 7.2.4.2.2UK Topical Scar Treatment Market by Scar Type
    - 7.2.4.2.3UK Topical Scar Treatment Market by Product
  - 7.2.4.3France Topical Scar Treatment Market
    - 7.2.4.3.1France Topical Scar Treatment Market by End-use
    - 7.2.4.3.2France Topical Scar Treatment Market by Scar Type
    - 7.2.4.3.3France Topical Scar Treatment Market by Product
  - 7.2.4.4Russia Topical Scar Treatment Market
    - 7.2.4.4.1Russia Topical Scar Treatment Market by End-use
    - 7.2.4.4.2Russia Topical Scar Treatment Market by Scar Type
    - 7.2.4.4.3Russia Topical Scar Treatment Market by Product
  - 7.2.4.5Spain Topical Scar Treatment Market
    - 7.2.4.5.1Spain Topical Scar Treatment Market by End-use
    - 7.2.4.5.2Spain Topical Scar Treatment Market by Scar Type
    - 7.2.4.5.3Spain Topical Scar Treatment Market by Product
  - 7.2.4.6Italy Topical Scar Treatment Market
    - 7.2.4.6.1Italy Topical Scar Treatment Market by End-use
    - 7.2.4.6.2Italy Topical Scar Treatment Market by Scar Type
    - 7.2.4.6.3Italy Topical Scar Treatment Market by Product
  - 7.2.4.7Rest of Europe Topical Scar Treatment Market
    - 7.2.4.7.1Rest of Europe Topical Scar Treatment Market by End-use
    - 7.2.4.7.2Rest of Europe Topical Scar Treatment Market by Scar Type
    - 7.2.4.7.3Rest of Europe Topical Scar Treatment Market by Product
7.3Asia Pacific Topical Scar Treatment Market
- 7.3.1Asia Pacific Topical Scar Treatment Market by End-use
  - 7.3.1.1Asia Pacific Hospitals Market by Country
  - 7.3.1.2Asia Pacific Clinics Market by Country
  - 7.3.1.3Asia Pacific Homecare Market by Country
- 7.3.2Asia Pacific Topical Scar Treatment Market by Scar Type
  - 7.3.2.1Asia Pacific Atrophic Scars Market by Country
  - 7.3.2.2Asia Pacific Hypertrophic & Keloid Scars Market by Country
  - 7.3.2.3Asia Pacific Contracture Scars Market by Country
  - 7.3.2.4Asia Pacific Stretch Marks Market by Country
- 7.3.3Asia Pacific Topical Scar Treatment Market by Product
  - 7.3.3.1Asia Pacific Creams Market by Country
  - 7.3.3.2Asia Pacific Gels Market by Country
  - 7.3.3.3Asia Pacific Silicon Sheets Market by Country
  - 7.3.3.4Asia Pacific Others Market by Country
- 7.3.4Asia Pacific Topical Scar Treatment Market by Country
  - 7.3.4.1China Topical Scar Treatment Market
    - 7.3.4.1.1China Topical Scar Treatment Market by End-use
    - 7.3.4.1.2China Topical Scar Treatment Market by Scar Type
    - 7.3.4.1.3China Topical Scar Treatment Market by Product
  - 7.3.4.2Japan Topical Scar Treatment Market
    - 7.3.4.2.1Japan Topical Scar Treatment Market by End-use
    - 7.3.4.2.2Japan Topical Scar Treatment Market by Scar Type
    - 7.3.4.2.3Japan Topical Scar Treatment Market by Product
  - 7.3.4.3India Topical Scar Treatment Market
    - 7.3.4.3.1India Topical Scar Treatment Market by End-use
    - 7.3.4.3.2India Topical Scar Treatment Market by Scar Type
    - 7.3.4.3.3India Topical Scar Treatment Market by Product
  - 7.3.4.4South Korea Topical Scar Treatment Market
    - 7.3.4.4.1South Korea Topical Scar Treatment Market by End-use
    - 7.3.4.4.2South Korea Topical Scar Treatment Market by Scar Type
    - 7.3.4.4.3South Korea Topical Scar Treatment Market by Product
  - 7.3.4.5Singapore Topical Scar Treatment Market
    - 7.3.4.5.1Singapore Topical Scar Treatment Market by End-use
    - 7.3.4.5.2Singapore Topical Scar Treatment Market by Scar Type
    - 7.3.4.5.3Singapore Topical Scar Treatment Market by Product
  - 7.3.4.6Malaysia Topical Scar Treatment Market
    - 7.3.4.6.1Malaysia Topical Scar Treatment Market by End-use
    - 7.3.4.6.2Malaysia Topical Scar Treatment Market by Scar Type
    - 7.3.4.6.3Malaysia Topical Scar Treatment Market by Product
  - 7.3.4.7Rest of Asia Pacific Topical Scar Treatment Market
    - 7.3.4.7.1Rest of Asia Pacific Topical Scar Treatment Market by End-use
    - 7.3.4.7.2Rest of Asia Pacific Topical Scar Treatment Market by Scar Type
    - 7.3.4.7.3Rest of Asia Pacific Topical Scar Treatment Market by Product
7.4LAMEA Topical Scar Treatment Market
- 7.4.1LAMEA Topical Scar Treatment Market by End-use
  - 7.4.1.1LAMEA Hospitals Market by Country
  - 7.4.1.2LAMEA Clinics Market by Country
  - 7.4.1.3LAMEA Homecare Market by Country
- 7.4.2LAMEA Topical Scar Treatment Market by Scar Type
  - 7.4.2.1LAMEA Atrophic Scars Market by Country
  - 7.4.2.2LAMEA Hypertrophic & Keloid Scars Market by Country
  - 7.4.2.3LAMEA Contracture Scars Market by Country
  - 7.4.2.4LAMEA Stretch Marks Market by Country
- 7.4.3LAMEA Topical Scar Treatment Market by Product
  - 7.4.3.1LAMEA Creams Market by Country
  - 7.4.3.2LAMEA Gels Market by Country
  - 7.4.3.3LAMEA Silicon Sheets Market by Country
  - 7.4.3.4LAMEA Others Market by Country
- 7.4.4LAMEA Topical Scar Treatment Market by Country
  - 7.4.4.1Brazil Topical Scar Treatment Market
    - 7.4.4.1.1Brazil Topical Scar Treatment Market by End-use
    - 7.4.4.1.2Brazil Topical Scar Treatment Market by Scar Type
    - 7.4.4.1.3Brazil Topical Scar Treatment Market by Product
  - 7.4.4.2Argentina Topical Scar Treatment Market
    - 7.4.4.2.1Argentina Topical Scar Treatment Market by End-use
    - 7.4.4.2.2Argentina Topical Scar Treatment Market by Scar Type
    - 7.4.4.2.3Argentina Topical Scar Treatment Market by Product
  - 7.4.4.3UAE Topical Scar Treatment Market
    - 7.4.4.3.1UAE Topical Scar Treatment Market by End-use
    - 7.4.4.3.2UAE Topical Scar Treatment Market by Scar Type
    - 7.4.4.3.3UAE Topical Scar Treatment Market by Product
  - 7.4.4.4Saudi Arabia Topical Scar Treatment Market
    - 7.4.4.4.1Saudi Arabia Topical Scar Treatment Market by End-use
    - 7.4.4.4.2Saudi Arabia Topical Scar Treatment Market by Scar Type
    - 7.4.4.4.3Saudi Arabia Topical Scar Treatment Market by Product
  - 7.4.4.5South Africa Topical Scar Treatment Market
    - 7.4.4.5.1South Africa Topical Scar Treatment Market by End-use
    - 7.4.4.5.2South Africa Topical Scar Treatment Market by Scar Type
    - 7.4.4.5.3South Africa Topical Scar Treatment Market by Product
  - 7.4.4.6Nigeria Topical Scar Treatment Market
    - 7.4.4.6.1Nigeria Topical Scar Treatment Market by End-use
    - 7.4.4.6.2Nigeria Topical Scar Treatment Market by Scar Type
    - 7.4.4.6.3Nigeria Topical Scar Treatment Market by Product
  - 7.4.4.7Rest of LAMEA Topical Scar Treatment Market
    - 7.4.4.7.1Rest of LAMEA Topical Scar Treatment Market by End-use
    - 7.4.4.7.2Rest of LAMEA Topical Scar Treatment Market by Scar Type
    - 7.4.4.7.3Rest of LAMEA Topical Scar Treatment Market by Product

Chapter 8.Company Profiles

8.1Smith & Nephew PLC
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Regional and Segmental Analysis
- 8.1.4Research & Development Expense
- 8.1.5SWOT Analysis
8.2Lumenis Be Ltd.
- 8.2.1Company Overview
- 8.2.2Recent strategies and developments:
  - 8.2.2.1Partnerships, Collaborations, and Agreements:
  - 8.2.2.2Product Launches and Product Expansions:
- 8.2.3SWOT Analysis
8.3Merz Pharma GmbH & Co. KGaA
- 8.3.1Company Overview
- 8.3.2Recent strategies and developments:
  - 8.3.2.1Partnerships, Collaborations, and Agreements:
- 8.3.3SWOT Analysis
8.4Sonoma Pharmaceuticals, Inc.
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Regional Analysis
- 8.4.4Research & Development Expenses
- 8.4.5Recent strategies and developments:
  - 8.4.5.1Product Launches and Product Expansions:
- 8.4.6SWOT Analysis
8.5Molnlycke Health Care AB
- 8.5.1Company Overview
- 8.5.2SWOT Analysis
8.6Suneva Medical, Inc.
- 8.6.1Company Overview
- 8.6.2Recent strategies and developments:
  - 8.6.2.1Product Launches and Product Expansions:
- 8.6.3SWOT Analysis
8.7Perrigo Company PLC
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Segmental and Regional Analysis
- 8.7.4Research & Development Expenses
- 8.7.5SWOT Analysis
8.8Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
- 8.8.1Company Overview
- 8.8.2Recent strategies and developments:
  - 8.8.2.1Partnerships, Collaborations, and Agreements:
  - 8.8.2.2Product Launches and Product Expansions:
- 8.8.3SWOT Analysis
8.9Newmedical Technology Inc.
- 8.9.1Company Overview
- 8.9.2SWOT Analysis
8.10.Integra LifeSciences Holdings Corporation
- 8.10.1Company Overview
- 8.10.2Financial Analysis
- 8.10.3Segmental and Regional Analysis
- 8.10.4Research & Development Expenses
- 8.10.5SWOT Analysis

한글목차

목차

제1장 시장 범위와 조사 방법

제2장 시장 요람

제3장 시장 개요

제4장 세계 시장 : 최종 용도별

제5장 세계 시장 : 상처 자국 유형별

제6장 세계 시장 : 제품별

제7장 세계 시장 : 지역별